Industry context
Tevogen Bio Holdings Inc [TVGNW]
Paskutinį kartą atnaujinta 25 Jun 2026 @ 15:59 (Exchange is closed)
Paskutinė: $0.0559
-2.44%
2.65
GaG Algo Score™
v1.0
Trumpas
2.65
Vidutinis
3.53
Ilgas
2.78
Linija
Pivot duomenys
Pivot statistika
| Rodiklis | Vidurkis | Mediana | Stand. nuokr. |
|---|---|---|---|
| Prieaugis % | 27.30% | 27.30% | 0.00% |
| Nuostolis % | -15.91% | -15.91% | 7.17% |
| Trukmė | 18.0d | 24d | 12.2d |
| Rasta pivot taškų | 4 |
| Prieaugio/nuostolio atkarpos | 3 (1 Prieaugis / 2 Nuostolis) |
| Paskutinis pivot | Bottom @ $0.03 data 2026-06-10 |
| Pokytis nuo paskutinio pivot | $0.02 (64.90%) |
Kito pivot prognozė Paskutinė: $0.06
| Prognozuojamas kitas tipas | Top |
| Prognozuojama kaina (vid.) | $0.04 |
| Prognozuojama kaina (mediana) | $0.04 |
| Prognozuojamas kainos intervalas (~68%) | $0.04 - $0.04 |
| Pokytis iki vidutinio tikslo | $-0.01 (-22.80%) |
| Prognozuojama data (vid.) | 2026-06-28 |
| Prognozuojamas datos intervalas (~68%) | 2026-06-15 - 2026-07-10 |
| Pagrindas | Based on 1 historical gains (Avg: 27.30%, Median: 27.30%, StdDev: 0.00%) and duration (Avg: 18.0 days, StdDev: 12.2 days) |
| Pastaba | Ranges assume ~normal distribution & historical patterns repeat. Use with caution. |
Tevogen Bio Holdings Inc fell moderately, down -2.44% on Thursday.
Tevogen Bio Holdings Inc (TVGNW) stock price suffered a considerable decline on Thursday after the stock fell $-0.00140 (-2.44%) from the previous session on normal volume. The stock fell slightly more than the NASDAQ which was down -0.46%. With 209 922 shares traded, volume yesterday reached $11 735. This was 166 606 shares more than the prior day. Compared to the 10-day average of 201 916 shares, volume was more than the average.
Tevogen Bio Holdings Inc signals
The last moves is moving the stock closer to overbought levels, which may signal growing momentum but also increasing risk of a pullback. The price is above both the short- and long-term averages, and the short-term average is above the long-term average, confirming an established up-trend. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (30%), medium- (30%), and long-term (30%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.
Tevogen Bio Holdings Inc Support & Resistance Levels
The stock is approaching the closest resistance level at $0.0575. approximately $0.00160 (2.86%) away. Approaching it. Breaking above this level could signal further upside where next resistance level will be found at $0.0579. On a fall back there will be support at $0.0499 The dis das resistance s10.0499 -
Tevogen Bio Holdings Inc Evaluation
- Trumpas balas: 2.65
- Vidutinis balas: 3.53
- Ilgas balas: 2.78
Ownership flow
GetAGraph InsiderPower
Transactions
25
Buy power
721.8K
Sell power
4.30M
Reliability
97/100
Buy / sell
0.17
Hist. corr.
-0.27
Latest signal
Sell 2026-06-25
Officer 20
Director 5
2026-03-13
Flomenberg Neal Officer
Sell 501
2026-03-11
Flomenberg Neal Officer
Sell 452
2026-03-10
Flomenberg Neal Officer
Sell 19
2025-12-18
Saadi Ryan H. Officer
Sell 50 000
2025-12-11
Desai Kirti Officer
Sell 300 000
2025-12-11
Saadi Ryan H. Officer
Sell 460 000
Relationship map
Correlation snapshot
Positioning pressure
Short interest pressure
Short interest
0.00%
Of outstanding shares
Short float
0.01%
Of tradable float
Days to cover
1.000
Short interest divided by average volume
Squeeze probability
0.10%
+190.62% change
Short positioning does not currently stand out as a dominant risk factor.
Updated 2026-05-29Company context
Company profile
Birža:
NASDAQ
Sektorius:
Healthcare
Pramonė:
Biotechnology
Currency
USD
Tevogen Bio Holdings Inc is a clinicalstage biotechnology company focused on developing readytouse precision T cell therapies Their research and development efforts span virology oncology and neurological conditions The companys flagship experimental treatment TVGN 489 is a precision T cell product designed to meet the unmet needs of individuals severely affected by acute COVID19 as well as a specific group of patients struggling with long COVID Tevogen Bio Holdings Inc is headquartered in Warren New Jersey
Navigation